• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中的巨噬细胞生物学和免疫抑制机制。

Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer.

机构信息

Breast Tumor Immunology Laboratory, Dana-Farber Cancer Institute, Boston, MA, United States.

Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, United States.

出版信息

Front Immunol. 2021 Apr 23;12:643771. doi: 10.3389/fimmu.2021.643771. eCollection 2021.

DOI:10.3389/fimmu.2021.643771
PMID:33968034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8102870/
Abstract

Macrophages are crucial innate immune cells that maintain tissue homeostasis and defend against pathogens; however, their infiltration into tumors has been associated with adverse outcomes. Tumor-associated macrophages (TAMs) represent a significant component of the inflammatory infiltrate in breast tumors, and extensive infiltration of TAMs has been linked to poor prognosis in breast cancer. Here, we detail how TAMs impede a productive tumor immunity cycle by limiting antigen presentation and reducing activation of cytotoxic T lymphocytes (CTLs) while simultaneously supporting tumor cell survival, angiogenesis, and metastasis. There is an urgent need to overcome TAM-mediated immune suppression for durable anti-tumor immunity in breast cancer. To date, failure to fully characterize TAM biology and classify multiple subsets has hindered advancement in therapeutic targeting. In this regard, the complexity of TAMs has recently taken center stage owing to their subset diversity and tightly regulated molecular and metabolic phenotypes. In this review, we reveal major gaps in our knowledge of the functional and phenotypic characterization of TAM subsets associated with breast cancer, before and after treatment. Future work to characterize TAM subsets, location, and crosstalk with neighboring cells will be critical to counteract TAM pro-tumor functions and to identify novel TAM-modulating strategies and combinations that are likely to enhance current therapies and overcome chemo- and immuno-therapy resistance.

摘要

巨噬细胞是维持组织内稳态和抵御病原体的重要先天免疫细胞;然而,它们浸润肿瘤与不良预后相关。肿瘤相关巨噬细胞(TAMs)是乳腺癌炎症浸润的重要组成部分,TAMs 的广泛浸润与乳腺癌预后不良相关。在这里,我们详细介绍了 TAMs 如何通过限制抗原呈递和减少细胞毒性 T 淋巴细胞(CTL)的激活,同时支持肿瘤细胞存活、血管生成和转移,来阻碍有效的肿瘤免疫循环。为了在乳腺癌中获得持久的抗肿瘤免疫,迫切需要克服 TAM 介导的免疫抑制。迄今为止,由于未能充分表征 TAM 生物学并对多个亚群进行分类,因此在治疗靶向方面进展缓慢。在这方面,由于 TAMs 亚群多样性和严格调控的分子和代谢表型,其复杂性最近成为关注焦点。在这篇综述中,我们揭示了与乳腺癌治疗前后 TAM 亚群功能和表型特征相关的主要知识空白。未来对 TAM 亚群的特征、位置以及与邻近细胞的相互作用进行研究,对于抵抗 TAM 促进肿瘤的功能以及鉴定新的 TAM 调节策略和组合以增强现有治疗方法并克服化疗和免疫治疗耐药性将是至关重要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eed/8102870/2ef49547f91b/fimmu-12-643771-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eed/8102870/54c01b4aa92a/fimmu-12-643771-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eed/8102870/66ada16d3a99/fimmu-12-643771-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eed/8102870/827c1d013bfb/fimmu-12-643771-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eed/8102870/2ef49547f91b/fimmu-12-643771-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eed/8102870/54c01b4aa92a/fimmu-12-643771-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eed/8102870/66ada16d3a99/fimmu-12-643771-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eed/8102870/827c1d013bfb/fimmu-12-643771-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eed/8102870/2ef49547f91b/fimmu-12-643771-g0004.jpg

相似文献

1
Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer.乳腺癌中的巨噬细胞生物学和免疫抑制机制。
Front Immunol. 2021 Apr 23;12:643771. doi: 10.3389/fimmu.2021.643771. eCollection 2021.
2
Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.巨噬细胞极化:针对乳腺癌中肿瘤相关巨噬细胞的抗癌策略
J Cell Biochem. 2017 Sep;118(9):2484-2501. doi: 10.1002/jcb.25895. Epub 2017 May 30.
3
The role of tumor-associated macrophage in breast cancer biology.肿瘤相关巨噬细胞在乳腺癌生物学中的作用。
Histol Histopathol. 2018 Feb;33(2):133-145. doi: 10.14670/HH-11-916. Epub 2017 Jul 6.
4
Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progression.热休克蛋白 27 区分了可能支持人类乳腺癌进展的耐受性巨噬细胞。
Cancer Res. 2011 Jan 15;71(2):318-27. doi: 10.1158/0008-5472.CAN-10-1778. Epub 2011 Jan 11.
5
Single-cell transcriptional atlas of tumor-associated macrophages in breast cancer.乳腺癌肿瘤相关巨噬细胞的单细胞转录组图谱。
Breast Cancer Res. 2024 Sep 4;26(1):129. doi: 10.1186/s13058-024-01887-6.
6
Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.肿瘤相关巨噬细胞作为乳腺癌的治疗靶点。
Adv Exp Med Biol. 2017;1026:331-370. doi: 10.1007/978-981-10-6020-5_16.
7
TFEB is a master regulator of tumor-associated macrophages in breast cancer.TFEB 是乳腺癌中肿瘤相关巨噬细胞的主调控因子。
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2020-000543.
8
The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies.肿瘤相关巨噬细胞在胶质瘤新生血管形成中的作用及其对抗血管生成策略的影响。
Neuro Oncol. 2017 Oct 19;19(11):1435-1446. doi: 10.1093/neuonc/nox081.
9
CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.肿瘤相关巨噬细胞分泌的CCL18促进乳腺癌血管生成。
Oncotarget. 2015 Oct 27;6(33):34758-73. doi: 10.18632/oncotarget.5325.
10
The roles of tumor-associated macrophages in tumor angiogenesis and metastasis.肿瘤相关巨噬细胞在肿瘤血管生成和转移中的作用。
Cell Immunol. 2020 Jul;353:104119. doi: 10.1016/j.cellimm.2020.104119. Epub 2020 May 4.

引用本文的文献

1
Dual roles of innate immune cells and cytokines in shaping the breast cancer microenvironment.天然免疫细胞和细胞因子在塑造乳腺癌微环境中的双重作用。
Front Immunol. 2025 Aug 20;16:1654947. doi: 10.3389/fimmu.2025.1654947. eCollection 2025.
2
Identification and validation of cell phagocytosis-related genes for prognosis in breast cancer: A study of diagnostic relevance in breast cancer.乳腺癌中用于预后的细胞吞噬相关基因的鉴定与验证:一项关于乳腺癌诊断相关性的研究
Medicine (Baltimore). 2025 Aug 1;104(31):e43540. doi: 10.1097/MD.0000000000043540.
3
Comprehensive analysis of glycosyl transferase-related subtypes reveals prognostic genes and immune landscape in breast cancer.

本文引用的文献

1
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer.靶向免疫抑制性巨噬细胞可克服BRCA1相关三阴性乳腺癌中的PARP抑制剂耐药性。
Nat Cancer. 2021 Jan;2(1):66-82. doi: 10.1038/s43018-020-00148-7. Epub 2020 Dec 14.
2
Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer.威罗菲尼联合顺铂治疗转移性三阴性乳腺癌的临床疗效和分子反应相关性研究
Clin Cancer Res. 2021 Feb 15;27(4):983-991. doi: 10.1158/1078-0432.CCR-20-3089. Epub 2020 Nov 30.
3
糖基转移酶相关亚型的综合分析揭示了乳腺癌的预后基因和免疫格局。
Medicine (Baltimore). 2025 Aug 1;104(31):e43523. doi: 10.1097/MD.0000000000043523.
4
Integrated network toxicology and bioinformatics reveal PFAS-driven prognostic biomarkers and molecular mechanisms in breast cancer: insights from transcriptome analysis and molecular docking.综合网络毒理学和生物信息学揭示全氟和多氟烷基物质驱动的乳腺癌预后生物标志物及分子机制:转录组分析和分子对接的见解
Discov Oncol. 2025 Jul 24;16(1):1400. doi: 10.1007/s12672-025-03084-z.
5
Tumor-Associated Macrophage in Breast Tumor Microenvironment.乳腺肿瘤微环境中的肿瘤相关巨噬细胞
Int J Mol Sci. 2025 Jun 21;26(13):5973. doi: 10.3390/ijms26135973.
6
Spatial profiling reveals unique immune microenvironment in premenopausal triple-negative breast cancer associated with therapy response.空间分析揭示了绝经前三阴性乳腺癌中与治疗反应相关的独特免疫微环境。
J Transl Med. 2025 Jul 10;23(1):761. doi: 10.1186/s12967-025-06786-8.
7
Developmental immune network of airway lymphocytes and innate immune cells in patients with stable COPD.稳定期慢性阻塞性肺疾病患者气道淋巴细胞与固有免疫细胞的发育性免疫网络
Front Immunol. 2025 Jun 16;16:1614655. doi: 10.3389/fimmu.2025.1614655. eCollection 2025.
8
Progress of Traditional Chinese Medicine in Regulating Immune Cell in the Tumor Microenvironment of Triple-Negative Breast Cancer.中医药调控三阴性乳腺癌肿瘤微环境中免疫细胞的研究进展
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251349824. doi: 10.1177/15347354251349824. Epub 2025 Jun 20.
9
New Insights Into Adipokines and the Tumor Microenvironment in Breast Cancer.乳腺癌中脂肪因子与肿瘤微环境的新见解
Cancer Control. 2025 Jan-Dec;32:10732748251347917. doi: 10.1177/10732748251347917. Epub 2025 Jun 10.
10
CD105 fibroblasts support an immunosuppressive niche in women at high risk of breast cancer initiation.CD105 成纤维细胞在乳腺癌发病高危女性中支持免疫抑制微环境。
Breast Cancer Res. 2025 May 15;27(1):81. doi: 10.1186/s13058-025-02040-7.
Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of -Mutant Breast Cancer.
甾体激素受体和浸润免疫细胞状态揭示了 - 突变型乳腺癌的治疗弱点。
Cancer Res. 2021 Feb 1;81(3):732-746. doi: 10.1158/0008-5472.CAN-20-1200. Epub 2020 Nov 12.
4
Local Targeting of Lung-Tumor-Associated Macrophages with Pulmonary Delivery of a CSF-1R Inhibitor for the Treatment of Breast Cancer Lung Metastases.肺内递送 CSF-1R 抑制剂靶向肺肿瘤相关巨噬细胞治疗乳腺癌肺转移。
Mol Pharm. 2020 Dec 7;17(12):4691-4703. doi: 10.1021/acs.molpharmaceut.0c00983. Epub 2020 Nov 10.
5
Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers.富含免疫细胞的雌激素受体阳性与富含免疫细胞的三阴性乳腺癌之间的免疫学差异
JCO Precis Oncol. 2020 Jun 26;4. doi: 10.1200/PO.19.00350. eCollection 2020.
6
Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.浸润性乳腺癌中肿瘤相关巨噬细胞的病理评估及其组织学定位。
J Egypt Natl Canc Inst. 2020 Jan 27;32(1):6. doi: 10.1186/s43046-020-0018-8.
7
Tumor-Associated Macrophages: Recent Insights and Therapies.肿瘤相关巨噬细胞:最新见解与治疗方法
Front Oncol. 2020 Feb 25;10:188. doi: 10.3389/fonc.2020.00188. eCollection 2020.
8
Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis.抗肿瘤治疗中针对 CD47/SIRPα 轴的研究进展。
Front Immunol. 2020 Jan 28;11:18. doi: 10.3389/fimmu.2020.00018. eCollection 2020.
9
Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice.评估人癌组织中肿瘤相关巨噬细胞向M1和M2表型的极化:常规临床实践中的技术细节与挑战
Front Oncol. 2020 Jan 24;9:1512. doi: 10.3389/fonc.2019.01512. eCollection 2019.
10
Macrophage Colony-stimulating Factor Mediates the Recruitment of Macrophages in Triple negative Breast Cancer.巨噬细胞集落刺激因子介导巨噬细胞在三阴性乳腺癌中的募集。
Int J Biol Sci. 2019 Nov 8;15(13):2859-2871. doi: 10.7150/ijbs.39063. eCollection 2019.